Outcome of chemo-immunotherapy for extensive-stage small-cell lung cancer according to potential clinical trial eligibility: 3-year outcomes from prospective cohort study. Tifcemalimab combined with ...
The typical all-source intelligence analyst must generate products that result from the fusion and correlation of structured and unstructured text reporting with sensor and imagery data sources. This ...
Chen et al. construct a comprehensive immune landscape of lymphatic malformations (LMs) atlas at single-cell resolution, uncovering pro-inflammatory responses and immune dysfunction characteristic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results